Inclusion Criteria:  Eligible patients are those over 18 years of age with WHO grade 3 or 4 oral mucositis receiving radio- or chemotherapy as treatment for head and neck cancer.  Exclusion Criteria:  Patients with hematologic malignancies or those with known allergic reactions to the drug.